No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs10237790 |
chr7:14542836-14542837 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs560838996 |
chr7:14542845-14542846 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs10251573 |
chr7:14542889-14542890 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
4 |
rs546482406 |
chr7:14542934-14542935 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs189720956 |
chr7:14542944-14542945 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs139637222 |
chr7:14542991-14542992 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs77133914 |
chr7:14543045-14543046 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs74743971 |
chr7:14543056-14543057 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs373070083 |
chr7:14543058-14543059 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs34302167 |
chr7:14543094-14543095 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs537165446 |
chr7:14543139-14543140 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs150516845 |
chr7:14543170-14543171 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs537530352 |
chr7:14543190-14543191 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs557560418 |
chr7:14543213-14543214 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs147009915 |
chr7:14543255-14543256 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs567183003 |
chr7:14543261-14543262 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs556889972 |
chr7:14543318-14543319 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs536985173 |
chr7:14543329-14543330 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs181240480 |
chr7:14543375-14543376 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs576834686 |
chr7:14543403-14543404 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs151020913 |
chr7:14543442-14543443 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs372941932 |
chr7:14543537-14543538 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs573530053 |
chr7:14543539-14543540 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs545404907 |
chr7:14543601-14543602 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs371048660 |
chr7:14543643-14543644 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs140887676 |
chr7:14543644-14543645 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs185686065 |
chr7:14543663-14543664 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs533299662 |
chr7:14543763-14543764 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs190489220 |
chr7:14543780-14543781 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs544355110 |
chr7:14543823-14543824 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs150181238 |
chr7:14543890-14543891 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs529850651 |
chr7:14543901-14543902 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs539994723 |
chr7:14543945-14543946 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs560040134 |
chr7:14543970-14543971 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs536222383 |
chr7:14544003-14544004 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs553038086 |
chr7:14544013-14544014 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs183033655 |
chr7:14544018-14544019 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs187331743 |
chr7:14544028-14544029 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs192031060 |
chr7:14544044-14544045 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs182665897 |
chr7:14544045-14544046 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs547967100 |
chr7:14544048-14544049 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs112391867 |
chr7:14544055-14544056 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs568121351 |
chr7:14544066-14544067 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs181414161 |
chr7:14544084-14544085 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs187625667 |
chr7:14544126-14544127 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs558847056 |
chr7:14544127-14544128 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs192815492 |
chr7:14544132-14544133 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs138733618 |
chr7:14544153-14544154 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs12533779 |
chr7:14544156-14544157 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs558332273 |
chr7:14544172-14544173 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|